Effects of Acupuncture on Neurological Disease in Clinical- and Animal-Based Research

Acupuncture has been used as complementary medicine in China, Korea, and Japan for hundreds of years, but it has only recently gained worldwide scientific recognition. This scientific review, conducted by researchers at the Beijing University of Chinese Medicine, examined the evidence on the efficacy of acupuncture in the treatment of neurological diseases, especially Alzheimer's disease (AD) and Parkinson's disease (PD). Neurological diseases represent a growing public health challenge worldwide, particularly with the aging of the population. Alzheimer's disease accounts for 60–80% of dementia cases, while Parkinson's disease is the most common movement disorder globally.

Both conditions share similar pathological features, including accumulation of abnormal proteins, neuronal death, and changes in brain neurotransmitters.

The study systematically analyzed clinical and experimental evidence on the effects of acupuncture in these neurological conditions. The researchers reviewed dozens of randomized controlled clinical trials, as well as studies in animal models. The methodology included analysis of clinical trials with hundreds of patients, functional neuroimaging studies using magnetic resonance imaging and positron emission tomography, and experiments in animal models of neurodegenerative diseases. The aim was to understand both the clinical efficacy and the biological mechanisms by which acupuncture may benefit patients with these conditions.

The results for Alzheimer's disease were particularly encouraging. In a pooled analysis of ten clinical trials involving 585 patients, acupuncture demonstrated significant improvements in scores on the Mini-Mental State Examination, a standard test for assessing cognitive function. When combined with medications such as donepezil, acupuncture proved more effective than the medication alone. In a larger clinical trial with 87 patients with mild-to-moderate Alzheimer's disease, those treated with acupuncture showed greater cognitive improvement than the group receiving medication only.

Neuroimaging studies revealed that acupuncture increases cerebral glucose metabolism in regions important for memory, such as the hippocampus and frontal cortex. Animal research has shown that acupuncture reduces the accumulation of beta-amyloid protein, a hallmark of Alzheimer's disease, and protects neurons against cell death.

For Parkinson's disease, the results were also promising. Clinical studies have shown that acupuncture may improve motor symptoms, rigidity, balance, and gait in patients with Parkinson's. A systematic review of eleven studies with 831 patients showed that acupuncture combined with antiparkinsonian medications was more effective than medication alone. The technique also demonstrated benefits for non-motor symptoms frequent in the disease, such as sleep disturbances, fatigue, and digestive problems.

Animal experiments revealed that acupuncture protects dopamine-producing neurons, the neurotransmitter deficient in Parkinson's disease. Neuroimaging studies showed that acupuncture activates brain circuits important for motor control, including the basal ganglia and motor cortex.

These findings have important implications for patients and health professionals. For patients with Alzheimer's and Parkinson's, acupuncture represents a safe and potentially effective therapeutic option that may complement conventional treatments. The safety profile of acupuncture has been excellent, with only seven adverse reactions in more than 3,400 patients studied. For family caregivers, acupuncture offers hope of improvement in patients' quality of life.

Health professionals may consider integrating acupuncture into treatment plans, especially for patients who do not respond adequately to medications alone or who experience significant side effects. The evidence suggests that acupuncture works through multiple neuroprotective mechanisms, including reduction of brain inflammation, improvement in neuronal energy metabolism, and protection against cell death.

However, the study also identifies important limitations that must be considered. Many of the clinical trials analyzed had methodological limitations, including small sample sizes and difficulties in establishing appropriate control groups for acupuncture. The quality of the studies varied considerably, and some researchers questioned whether the observed benefits can be attributed to placebo effects. Additionally, the standardization of acupuncture protocols across different studies remains a challenge, since different acupuncture points and stimulation techniques were used.

Although the results are encouraging, more high-quality clinical trials are needed, with larger numbers of participants and longer follow-up periods, to definitively establish the efficacy of acupuncture as a treatment for neurodegenerative diseases. Future research should also focus on identifying the most effective acupuncture protocols and on fully understanding the mechanisms of action of this ancient therapeutic practice within the context of modern neuroscience.